Anya Biopharm Inc

NEW
ROCO:7776 (Taiwan)  
NT$ 31.8 (0%) Jul 10
At Loss
P/B:
3.88
Market Cap:
NT$ 1.56B ($ 48.62M)
Enterprise V:
NT$ 1.19B ($ 37.17M)
Volume:
123.13K
Avg Vol (2M):
74.34K
Trade In:
Volume:
123.13K
At Loss
Avg Vol (2M):
74.34K

Business Description

Description
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
Name Current Vs Industry Vs History
Cash-To-Debt
125.39
Equity-to-Asset
0.97
Debt-to-Equity
0.01
Debt-to-EBITDA
-0.05
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
85.3
Distress
Grey
Safe
Beneish M-Score
-0.31
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
65.63
9-Day RSI
64.58
14-Day RSI
62.13
3-1 Month Momentum %
-13.54
6-1 Month Momentum %
-45.57
12-1 Month Momentum %
-28.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
47.95
Quick Ratio
47.95
Cash Ratio
45.28
Days Sales Outstanding
115.11

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
0.05

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
99.14
Operating Margin %
-358.52
Net Margin %
-393.47
EBITDA Margin %
-374.16
FCF Margin %
-435.89
OCF Margin %
-429.8
ROE %
-15.14
ROA %
-14.7
ROIC %
-228.2
3-Year ROIIC %
-68.98
ROC (Joel Greenblatt) %
-482.35
ROCE %
-14.75

Financials

ROCO:7776's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Anya Biopharm Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 16.271
EPS (TTM) (NT$) -1.3
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 78.02
14-Day RSI 62.13
14-Day ATR (NT$) 2.643881
20-Day SMA (NT$) 27.2575
12-1 Month Momentum % -28.29
52-Week Range (NT$) 21.5 - 70.6
Shares Outstanding (Mil) 49.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anya Biopharm Inc Filings

Filing Date Document Date Form
No Filing Data

Anya Biopharm Inc Stock Events

Financials Calendars
Event Date Price (NT$)
No Event Data

Anya Biopharm Inc Frequently Asked Questions

What is Anya Biopharm Inc(ROCO:7776)'s stock price today?
The current price of ROCO:7776 is NT$31.80. The 52 week high of ROCO:7776 is NT$70.60 and 52 week low is NT$21.50.
When is next earnings date of Anya Biopharm Inc(ROCO:7776)?
The next earnings date of Anya Biopharm Inc(ROCO:7776) is .
Does Anya Biopharm Inc(ROCO:7776) pay dividends? If so, how much?
Anya Biopharm Inc(ROCO:7776) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Anya Biopharm Inc

No articles.